Receptor changes in brain tissue of rats treated as neonates with capsaicin

Journal of Chemical Neuroanatomy

Volumn 39, Issue 4, 2010, Pages 248-255

  Zavitsanou, K ^a,b   Dalton, Victoria S ^a,b   Wang, Hongqin ^a   Newson, Penny ^b,c   Chahl, Loris A ^b,c  

^a AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Cannabinoid; Capsaicin; Dopamine; Muscarinic; Serotonin; TRPV1

Indexed keywords

CANNABINOID 1 RECEPTOR; CAPSAICIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M4 RECEPTOR; SEROTONIN 2A RECEPTOR; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; BRAIN TISSUE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; FEMALE; MALE; MONOAMINERGIC SYSTEM; NEWBORN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SENSORY DEPRIVATION; SOMATOSENSORY STIMULATION;

ACETYLCHOLINE; AGING; ANIMALS; ANIMALS, NEWBORN; BRAIN; CAPSAICIN; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENDOCANNABINOIDS; FEMALE; MALE; NERVE NET; PAIN; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTORS, DOPAMINE; RECEPTORS, MUSCARINIC; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, SEROTONIN; SENSORY DEPRIVATION; SENSORY RECEPTOR CELLS; SENSORY SYSTEM AGENTS; SEROTONIN; TRPV CATION CHANNELS; UP-REGULATION;

EID: 77951025570     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2010.01.004     Document Type: Article

References (44)

1. Alex K.D., Pehek E.A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 2007, 113:296-320.
2. Caterina M.J., Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 2001, 24:487-517.
3. Cervero F., McRitchie H.A. Neonatal capsaicin and thermal nociception: a paradox. Brain Res. 1981, 215:414-418.
4. Chahl L.A. TRP's: links to schizophrenia?. Biochim. Biophys. Acta 1772, 968-977.
5. Chahl L.A., Newson P., van den Buuse M., Carr V. Characteristics of rats with reduced somatosensory input during development-a potential animal model of aspects of schizophrenia. Schizophr. Bull. 2007, 33:252-1252.
6. Cristino L., de Petrocellis L., Pryce G., Baker D., Guglielmotti V., Di Marzo V. Immunohistochemical localization of cannabinoid type1 and vanilloid transient receptor potential vanilloid type 1 receptors in mouse brain. Neuroscience 2006, 139:1405-1415.
7. Crook J.M., Dean B., Pavey G., Copolov D. The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia. Life Sci. 1999, 64:1761-1771.
8. Di Marzo V., Gobbi G., Szallasi A. Brain TRPV1: a depressing TR(i)P down memory lane?. Trends Pharmacol. Sci. 2008, 29:594-600.
9. du Bois T.M., Deng C., Bell W., Huang X.F. Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience 2006, 139:1397-1403.
10. Faulkner D.C., Growcott J.W. Effects of neonatal capsaicin administration on the nociceptive response of the rat to mechanical and chemical stimuli. J. Pharm. Pharmacol. 1980, 32:656-657.
11. 3-mediated indirect suppression through endocannabinoid signalling. Eur. J. Neurosci. 2004, 19:2682-2692.
12. Gavva N.R. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol. Sci. 2008, 29:550-557.
13. Gerber D.J., Sotnikova T.D., Gainetdinov R.R., Huang S.Y., Caron M.G., Tonegawa S. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:15312-15317.
14. Gibson H.E., Edwards J.G., Page R.S., Van Hook M.J., Kauer J.A. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron 2008, 57:746-759.
15. Gomeza J., Shannon H., Kostenis E., Felder C., Zhang L., Brodkin J., Grinberg A., Sheng H., Wess J. Pronounced pharmacological deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:1692-1697.
16. 4 muscarinic receptor knockout mice. Life Sci. 2001, 68:2457-2466.
17. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 1991, 43:143-201.
18. Jancsó G., Király E., Jancsó-Gábor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature (London) 1977, 270:741-743.
19. Kauer J.A., Gibson H.E. Hot flash: TRPV channels in the brain. Trends Neurosci. 2009, 32:215-224.
20. Kayser V., Elfassi I.E., Aubel B., Melfort M., Julius D., Gingrich J.A., Hamon M., Bourgoin S. Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice. Pain 2007, 130:235-248.
21. 2A receptor binding in the human brain and responses to painful heat stimulation. Neuroimage 2009, 44:1001-1007.
22. Maione S., Cristino L., Migliozzi A.L., Georgiou A.L., Starowicz K., Salt T.E., Di Marzo V. TRPV1 channels control synaptic plasticity in the developing superior colliculus. J. Physiol. 2009, 587:2521-2535.
23. Marinelli S., Di Marzo V., Florenzano F., Fezza F., Viscomi M.T., van der Stelt M., Bernardi G., Molinari M., Maccarrone M., Mercuri N.B. N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology 2007, 32:298-308.
24. Marsch R., Foeller E., Rammes G., Bunck M., Kössl M., Holsboer F., Zieglgänsberger W., Landgraf R., Lutz B., Wotjak C.T. Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J. Neurosci. 2007, 27:832-839.
25. Mezey E., Toth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:3655-3660.
26. Micale V., Cristino L., Tamburella A., Petrosino S., Leggio G.M., Drago F., Di Marzo V. Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: possible involvement of the endocannabinoid and endovanilloid systems. Neurobiol. Dis. 2009, doi:10.1016/j.nbd.2009.06.015.
27. Minuzzi L., Olsen A.K., Bender D., Arnfred S., Grant R., Danielsen E.H., Cumming P. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Gottingen minipig: comparison with results in vivo. Synapse 2006, 59:211-219.
28. Newell K.A., Deng C., Huang X.F. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Exp. Brain Res. 2006, 172:556-560.
29. Newson P., Lynch-Frame A., Roach R., Bennett S., Carr V., Chahl L.A. Intrinsic sensory deprivation induced by neonatal capsaicin treatment induces changes in rat brain and behaviour of possible relevance to schizophrenia. Br. J. Pharmacol. 2005, 146:408-418.
30. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, San Diego, CA, USA. 2nd ed.
31. Ritter S., Dinh T.T. Capsaicin-induced neuronal degeneration: silver impregnation of cell bodies, axons, and terminals in the central nervous system of the adult rat. J. Comp. Neurol. 1988, 271:79-90.
32. Ritter S., Dinh T.T. Capsaicin-induced neuronal degeneration in the brain and retina of preweanling rats. J. Comp. Neurol. 1990, 296:447-461.
33. Roberts J.C., Davis J.B., Benham C.D. (3H)Resiniferatoxin antoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res. 2004, 995:176-183.
34. Sadaka Y., Weinfeld E., Lev D.l., White E.L. Changes in mouse barrel synapses consequest to sensory deprivation from birth. J. Comp. Neurol. 2003, 457:75-86.
35. Shirakawa H., Yamaoka T., Sanpei K., Sasaoka H., Nakagawa T., Kaneko S. TRPV1 stimulation triggers apoptotic cell death of rat cortical neurons. Biochem. Biophys. Res. Commun. 2008, 377:1211-1215.
36. Starowicz K., Nigam S., Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther. 2007, 114:13-33.
37. Szallasi A., Blumberg P.M. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 1999, 51:159-212.
38. Szoke E., Czeh G., Szolcsanyi J., Seress L. Neonatal anandamide treatment results in prolonged mitochondrial damage in the vanilloid receptor type 1-immunoreactive B-type neurons of the rat trigeminal ganglion. Neuroscience 2002, 115:805-814.
39. Toth A., Boczan J., Kedei N., Lizanecz E., Bagi Z., Papp Z., Edes I., Csiba L., Blumberg P.M. Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res. Mol. Brain Res. 2005, 135:162-168.
40. Tzavara E.T., Li D.L., Moutsimilli L., Bisogno T., Di Marzo V., Phebus L.A., Nomikos G.G., Giros B. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Biol. Psychiatry 2006, 59:508-515.
41. Wall J.T., Xu J., Wang X. Human brain plasticity: an emerging view of the multiple substrates and mechanisms that cause cortical changes and related sensory dysfunction after injuries of sensory inputs from the body. Brain Res. Rev. 2002, 39:181-215.
42. 3H]spiperone binding in the anterior cingulate cortex of schizophrenia patients: an autoradiographic study. Neuroscience 2002, 109:709-716.
43. Zavitsanou K., Katsifis A., Mattner F., Huang X.F. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Neuropsychopharmacology 2004, 29:619-625.
44. Zavitsanou K., Katsifis A., Yu Y., Huang X.F. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders. Brain Res. Bull. 2005, 65:397-403.